Trending/Minnesota

Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds
ROCHESTER, Minn. — A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of…
Special Topics
Sign up

Mayo Clinic Connect
An online patient support community